Abstract
Type I insulin-like growth factor (IGF) receptor (IGF1R) inhibitors are new cancer therapies. Pitts and colleagues used in vitro data to "train" a predictive biomarker for an IGF1R tyrosine kinase inhibitor. Given the complexity of IGF signaling, additional layers of biomarker analysis will likely be needed to develop predictive factors.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 3091-3093 |
| Number of pages | 3 |
| Journal | Clinical Cancer Research |
| Volume | 16 |
| Issue number | 12 |
| DOIs | |
| State | Published - Jun 15 2010 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'How to train your biomarker'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS